Stockreport

Coherus prices biosimilar to Amgen's Neulasta at 33 percent discount [Reuters]

Coherus BioSciences, Inc.  (CHRS) 
Last coherus biosciences, inc. earnings: 2/27 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.coherus.com
PDF Coherus prices biosimilar to Amgen's Neulasta at 33 percent discount | Reuters 1 Min Read (Reuters) - Coherus BioSciences Inc said on Thursday it would price its biosimi [Read more]